Ghent University Academic Bibliography

Your filters: cql: author="Guan, Jikui" or (type any "bookEditor issueEditor" and editor="Guan, Jikui")

Add to list
- Miscellaneous
ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN

Marcus Borenas, Dan Lind, Adam Lehnberg, Edit Zentenius, Matilda Esselius, Eva Jennische, Joel Johansson, Jikui Guan, Agata Aniszewska, Jimmy Van den Eynden (UGent) , et al.

(2025) bioRxiv.
Add to list
- Journal Article
- A1
- open access
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

Marcus Borenäs, Ganesh Umapathy, Dan E. Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan Linus Gabre (UGent) , et al.

(2024) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 121(1).
Add to list
- Journal Article
- A1
- open access
Loss of RET promotes mesenchymal identity in neuroblastoma cells

Joachim T. Siaw, Jonatan Linus Gabre (UGent) , Ezgi Uçkun, Marc Vigny, Wancun Zhang, Jimmy Van den Eynden (UGent) , Bengt Hallberg, Ruth H. Palmer and Jikui Guan

(2021) CANCERS. 13(8).
Add to list
- Journal Article
- A1
- open access
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Marcus Borenäs, Ganesh Umapathy, Wei‐Yun Lai, Dan E Lind, Barbara Witek, Jikui Guan, Patricia Mendoza‐Garcia, Tafheem Masudi, Arne Claeys (UGent) , Tzu‐Po Chuang, et al.

(2021) EMBO JOURNAL. 40(3).
Add to list
Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways

Jimmy Van den Eynden (UGent) , Ganesh Umapathy, Arghavan Ashouri, Diana Cervantes-Madrid, Joanna Szydzik, Kristina Ruuth, Jan Koster, Erik Larsson, Jikui Guan, Ruth H Palmer, et al.

(2018) SCIENCE SIGNALING. 11(557).
Add to list
- Journal Article
- A2
Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

Jikui Guan, Susanne Fransson, Joachim Tetteh Siaw, Diana Treis, Jimmy Van den Eynden (UGent) , Damini Chand, Ganesh Umapathy, Kristina Ruuth, Petter Svenberg, Sandra Wessman, et al.

(2018) COLD SPRING HARBOR MOLECULAR CASE STUDIES. 4(4).

Academic Bibliography

ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN

ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition

Loss of RET promotes mesenchymal identity in neuroblastoma cells

ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

Contents

Support

Contact